R3 Bio
PrivateCompany Overview
R3 Bio is a biotechnology company that develops stem-cell-based in vitro research platforms designed to create human-relevant biological models for preclinical testing.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery
Business Model
B2B
Customer Profile
Services & Consulting, Data as a Service
AI Layer
Application
Keywords
in vitro modelsnew approach methodologiesNAMscellular reprogramminganimal-free testingpreclinical drug discoverystem-cell researchcontract research organizationCROtoxicology testingorgan-on-a-chipbiological modelingdrug safety testingcomputational biologyalternative testing methods
Historical Pricing
Historical view of private secondary pricing and transaction trends.
R3 Bio Comps
Public and private peers based on sector, stage, and business model.
| Company | Status | Est. Valuation | Rev Multiple |
|---|---|---|---|
| OpenAI | Private | $86.0B | ~40x |
| Cohere | Private | $5.0B | -- |
| Competitor 1 | Public | $XX.XB | XXx |
| Competitor 2 | Public | $XX.XB | XXx |
R3 Bio Funding Rounds
Historical fundraising activity
R3 Bio Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Immortal Dragons | Seed |
R3 Bio Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about R3 Bio's valuation, stock price, and market status.